Abstract bekijken

Deze abstract is toegekend aan sessie Poster Rapid Fire Presentation
TitelBotulinum toxin A in treatment for essential blepharospasm and hemifacial spasm: our results.
Abstract Nr.P09
DoelTo evaluate our clinical experience at the university clinic of Leuven with botulinum toxin A (BTA) for treatment of essential blepharospasm and hemifacial spasm.
MethodesRetrospective study with reviewing of patient charts. Several variables were studied: dosage of BTA, place of injections, interval of symptomatic relief and complications.
ResultatenThe study population consisted of 66 patients, 35 had essential blepharospasm and 31 had hemifacial spasm. Mean follow-up time was 6.9 years (1 – 24 years). The mean dosage was 20 IU BTA injection per side, with a mean interval of symptomatic relief of 3 months. Subjective success (improvement of severity class) was achieved in 92 %. Transient complications were upper eyelid ptosis in 3 % and diplopia in 1 % over the whole treatment period. A correlation was found between BTA injection in the temporal suprabrow area and the appearance of upper eyelid ptosis.
ConclusieThere are several methods described (different dosage and injection places) to threat essential blepharospasm and hemifacial spasm. With our method the success rate is more than 90% with a relative low complication rate.
Auteur 1
NaamVANDELANOTTE
InitialenS
InstituutUZ Leuven
StadLeuven
Auteur 2
NaamGOBIN
InitialenC
InstituutUZ Leuven
StadLeuven
top ^